表位
佐剂
癌症疫苗
材料科学
癌症免疫疗法
抗原
免疫疗法
免疫系统
CTL公司*
癌症研究
肽疫苗
免疫学
医学
CD8型
作者
Lingxiao Zhang,Xi-xiu Xie,Dong-qun Liu,Zhi Ping Xu
出处
期刊:Biomaterials
[Elsevier]
日期:2018-08-01
卷期号:174: 54-66
被引量:76
标识
DOI:10.1016/j.biomaterials.2018.05.015
摘要
Cancer immunotherapy has shown tremendous progresses in recent years for various cancers and layered double hydroxide (LDH) nanoparticles are demonstrated as effective adjuvants for protein-based vaccines. This research further shows that the colloidal stability of LDH-based vaccines significantly influences the therapeutic efficacy and LDH nanoparticles are able to adjuvant multiple tumor-associated antigen peptides to provoke strong cell-mediated immune responses for effective inhibition of cancer growth. The LDH-based multi-target therapeutic vaccines were constructed by assembling epitope peptides and CpG onto LDH nanoparticles. Using melanoma as the model cancer and Tyrosinase-related protein 2 (Trp2) peptide as the model antigen, we demonstrated that dispersion-stable LDH-based vaccine induced stronger cytotoxic T-lymphocyte (CTL) responses and significantly inhibited tumor growth in comparison with aggregated LDH-based vaccine. We further constructed multi-target dispersion-stable LDH-based vaccine by co-loading Trp2, two mutated epitopes (M27 and M30) and CpG, which showed remarkable inhibition of melanoma growth. These results suggest that dispersion-stable LDH nanoparticles are an ideal platform to load multi-antigens and immune stimulants as effective personalized therapeutic cancer vaccines.
科研通智能强力驱动
Strongly Powered by AbleSci AI